GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Fresenius Medical Care Corporation (FMS) [hlAlert]

Rating:
Hold FMS

Fresenius Medical Care Corporation (FMS) rated Hold by Societe Generale

Posted on: Thursday,  Aug 13, 2015  10:25 AM ET by Societe Generale

Societe Generale rated Hold Fresenius Medical Care Corporation (NYSE: FMS) on 08/13/2015. Previously Societe Generale rated Buy Fresenius Medical Care Corporation (NYSE: FMS)
on 08/31/2012., when the stock price was $36.33. Since then, Fresenius Medical Care Corporation has lost 13.40% as of 08/06/2013's recent price of $31.46.
If you would have followed the previous Societe Generale's recommendation on FMS, you would have lost 13.4% of your investment in 340 days.

Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA), is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services. The Company?s dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. At December 31, 2008, it provided dialysis treatment to 184,086 patients in 2,388 clinics worldwide located in more than 30 countries. In the United States, it also performs clinical laboratory testing and provides inpatient dialysis services and other services under contract to hospitals. During the year ended December 31, 2008, it provided 27.9 million dialysis treatments. It also develops and manufactures a range of equipments, systems and disposable products, which it sells to customers in over 115 countries.

Societe Generale
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/13/2015 10:25 AM Hold
None
40.64
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/6/2013 8:25 AM Hold
None
31.46
8/31/2012 8:25 AM Buy
None
36.33

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy